BO1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - BioCryst Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 7.926 EUR -2.39% Market Closed

Market Cap: €2.5B

B	BioCryst Pharmaceuticals Inc XMUN:BO1	US
	Rexel SA F:E7V	FR
I	Iovance Biotherapeutics Inc F:2LB	US
I	Imax Corp F:IMA	CA
P	Prudential PLC F:PRU2	UK
	Shanghai Electric Group Co Ltd OTC:SIELF	CN

Profitability Summary

BioCryst Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

98%

Gross Margin is Increasing

97% > 98%

Exceptional Operating Margin

36%

Negative 3Y Average Operating Margin

-2%

Operating Margin is Increasing

-37% > 36%

Negative Net Margin

-52%

Negative 3Y Average Net Margin

-30%

Net Margin is Increasing

-79% > -52%

Exceptional Free Cash Flow Margin

35%

Negative 3Y Average Free Cash Flow Margin

-6%

Free Cash Flow Margin is Increasing

-40% > 35%

Exceptional ROE

91%

Exceptional 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.